Chart of the month

Tue Jun 1, 2004



CCL Fund

Castle Creek Lifescience Partners' CCL Fund has considerably outperformed both the NASDAQ and the Absolute Return Tech index by using

TAKE A FREE TRIAL

The full contents of this article are available to active AR subscribers and trialists only.

To continue reading please,
take a free trialsubscribe or log in to AR.

Subscribe

Subscribers have unlimited access to all current and archive content. Start your subscription today - click on the button below.

Subscribe now